Adenosin to Rapidly Reverse Left Ventricle Impairment in Takotsubo Syndrome (TITAN)
Rapid Recovery of Left Ventricular Function in Patients With Takotsubo Syndrome Undergoing Systemic Infusion of Adenosine: a Randomized Controlled Trial (TITAN Study)
Sponsor: University Hospital of Ferrara
Terminated
inability to recruiti a sufficient number of patients
Other terminated trials from University Hospital of Ferrara
A PHASE2 clinical study on Takotsubo Cardiomyopathy and Takotsubo Syndrome, this trial is terminated or withdrawn. The trial is conducted by University Hospital of Ferrara and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Nov 2018 — Jan 2021 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital of Ferrara
For direct contact, visit the study record on ClinicalTrials.gov .